Jillian B. Thomsen, SVP & Chief Accounting Officer at NEKTAR THERAPEUTICS (NKTR), sold 3,856 shares at $31.37 ($121K) on 2019-05-16, disclosed to the SEC on 2019-05-17.
Seasonal sale ($121k) by SVP & Chief Accounting Officer — this insider has traded NKTR in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.37 | 1,928 | $60K | 50.0% |
| 2 | $31.37 | 1,928 | $60K | 50.0% |
| Total | $31.37 avg | 3,856 | $121K | 100% |
| Filing → |
| NKTR | SELL | 2022-08-17 | $10K | — | Filing → |
| NKTR | SELL | 2022-05-17 | $23K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $26K | — | Filing → |